HPV Vaccine for Adults: Who Needs It? Who Doesn't? HPV Vaccine for Adults: Who Needs It? Who Doesn't?
Find out which adults should be offered the HPV vaccine and who might want to skip it.Medscape Internal Medicine
Condition: Malaria, Malaria Vaccine, Insecticide-treated Bednets Interventions: Biological: RTS,S/AS01 malaria vaccine; Other: PBO bed nets Sponsors: Michigan State University; University of Malawi College of Medicine; University of Maryland, College Park; Boston University; National Institute of Allergy and Infectious Diseases (NIAID) Recruiting
One chart explains why slowing the spread of the infection is nearly as important as stopping it.
This article is republished from The Conversation under a Creative Commons license. Read the original article. The post TB, HIV and COVID-19: Urgent Questions as Three Epidemics Collide appeared first on Inter Press Service.
After President Trump, late last week, expressed great confidence in the promise of a new COVID-19 therapy that combines two existing prescription medications, supplies of these two drugs rapidly began disappearing from pharmacy shelves. The U.S. Food and Drug Administration allowed an Indian company previously restricted from importing drug products into the US to now start manufacturing one of the drugs. And U.S. plants began gearing up to produce enough to meet the surge in demand. But in those few days, a few people who began self medicating with the drugs in an effort to prevent COVID-19 have died, and others have bee...
The National Institute of Allergy and Infectious Diseases last month halted a highly anticipated clinical trial testing an investigational HIV vaccine regimen. After an interim review, a data and safety monitoring board found that the 2 experimental vaccines in the regimen were ineffective against HIV, although there were no safety concerns.
Last week, the first volunteers in a study of an experimental COVID-19 vaccine received their first doses, and the vaccine’s developer, Moderna Therapeutics, is already thinking ahead. Although testing on the vaccine will take at least a year to complete, the work could provide valuable information about how the immune system can fight coronaviruses and could give scientists a head start if any new outbreaks of the virus were to occur. Non-essential staff at Moderna Therapeutics’ manufacturing facility, in Norwood, Mass., including president Dr. Stephen Hoge, are working from home as recommended by public healt...
CONCLUSION: Over the past decade there have been significant advances in our knowledge of RSV molecular and structural biology, and in understanding the human immune response to RSV. Despite the barriers, there are several promising monoclonal antibodies and RSV vaccines undergoing clinical trials that hope to offer protection to the most vulnerable populations. PMID: 32217187 [PubMed - as supplied by publisher]
The high burden associated with respiratory syncytial virus (RSV), has made the development of RSV vaccine(s) a global health high priority. This review summarizes the journey to an RSV vaccine, the different strategies and challenges associated with the development of preventive strategies for RSV, and the diverse products that are undergoing clinical testing.
As I have made perfectly clear, any comments praising the Resident or defending his actions are likely to be non-publishable because they are almost certainly delusional. I do not come to this conclusion because of " bigotry " against the administration, I come to it because it is an ineluctable fact. What is so mysterious is why and how so many people cling to the delusion that there is anything admirable, competent, or praiseworthy about the most vile, repulsive, stupid, ignorant narcissistic psychopath who ever lived.I recommend this lengthy essay by Adam Serwer, which should be read in its entirety. It ...
Kids should receive the usual vaccines on time, but adult vaccines can wait, experts say. Many follow-up visits can be conducted via telehealth. Elective surgeries should be delayed.Medscape Medical News